Series A · Biotech · Paris, France · Founded 2023 · 51–200 employees
Spore.Bio is a Paris-based deeptech startup founded in 2023, developing AI-powered microbiology testing technologies to revolutionize quality control in industries like food and beverage, cosmetics, and pharmaceuticals. Their proprietary technology combines deep learning with biophotonics to detect bacterial contamination within seconds, aiming to replace traditional methods that have been in use for over 150 years. The company has raised over $35 million in funding, including a $23 million Series A round led by Singular in February 2025, and has secured major funding from Google.org's AI for Science fund to further their research and development efforts.